National Sickle Cell and Thalassemia Blood Group Genotyping Programme
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the upper-middle of the Health & Social Care band — a substantial contract for the sector. Based on 32,734 valued Health & Social Care tenders in our corpus.
The proposed 12-month programme will enable genotyping of blood groups by NHS BT in current patients (up to 17,800 patients) with either sickle cell or thalassemia.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- 5ff577fe-a93a-4fc2-a40e-2607f3244365
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CF-1892100D0O000000rwimUAA
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Health & Social Care
NHS England’s tender network
Assembling the network…